Full Press Release Details
CELLECTIS Shareholders Meeting December 22, 2023
Extraordinary Resolutions
| NB | Resolution | Result | For | Against | Vote withhold | Total votes | Shares represented by the votes cast | Percentage of the share capital represented by the votes cast | Out of vote voting rights | Null voting rights | Quorum | |||||||||||||||||||||||||||||||||||||||||||||
| Votes | % | Votes | % | Votes | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
| 1 | Creation of a class of preferred shares referred to as Class A preferred shares convertible into ordinary shares (the A Shares ) - determination of the specific rights attached to the A Shares - corresponding amendment to the bylaws | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1 | Carried | 26 188 875 | 99,65 | % | 92 063 | 0,35 | % | 35 416 | 26 280 938 | 21 466 266 | 29,917 | % | 0 | 0 | 29,917 | % | ||||||||||||||||||||||||||||||||||||||||
| 2 | Delegation of authority to the board of directors to increase the share capital by a maximum nominal amount of EUR 500,000, through the issuance of a maximum of 10,000,000 A Shares, with cancellation of the shareholders preferential subscription rights in favor of a named person | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Carried | 26 171 469 | 99,55 | % | 118 145 | 0,45 | % | 26 740 | 26 289 614 | 21 466 266 | 29,917 | % | 0 | 0 | 29,917 | % | ||||||||||||||||||||||||||||||||||||||||
| 3 | Creation of a class of preferred shares referred to as Class B preferred shares convertible into ordinary shares (the B Shares ) - determination of the specific rights attached to the B Shares - corresponding amendment to the bylaws | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Carried | 26 189 117 | 99,63 | % | 97 794 | 0,37 | % | 29 443 | 26 286 911 | 21 466 266 | 29,917 | % | 0 | 0 | 29,917 | % | ||||||||||||||||||||||||||||||||||||||||
| 4 | Delegation of authority to the board of directors to increase the share capital by a maximum nominal amount of EUR 900,000, through the issuance of a maximum of 18,000,000 B Shares, with cancellation of the shareholders preferential subscription rights in favor of a named person | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Carried | 26 198 396 | 99,63 | % | 96 411 | 0,37 | % | 21 547 | 26 294 807 | 21 466 266 | 29,917 | % | 0 | 0 | 29,917 | % | ||||||||||||||||||||||||||||||||||||||||
| 5 | Cancellation of the shareholders preferential subscription rights in favor of AstraZeneca Holdings B.V. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Carried | 26 205 300 | 99,67 | % | 88 077 | 0,33 | % | 22 977 | 26 293 377 | 21 466 266 | 29,917 | % | 0 | 0 | 29,917 | % | ||||||||||||||||||||||||||||||||||||||||
| 6 | Delegation of authority to the board of directors to carry out a share capital increase reserved for members of a company savings plan set up in accordance with Articles L. 3332-1 et seq. of the French Labor Code | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Rejected | 6 297 651 | 23,95 | % | 19 998 142 | 76,05 | % | 20 561 | 26 295 793 | 21 466 266 | 29,917 | % | 0 | 0 | 29,917 | % |
CELLECTIS Shareholders Meeting December 22, 2023
Ordinary Resolutions
| NB | Resolution | Result | For | Against | Vote withhold | Total votes | Shares represented by the votes cast | Percentage of the share capital represented by the votes cast | Out of vote voting rights | Null voting rights | Quorum | |||||||||||||||||||||||||||||||||||||||||||||
| Votes | % | Votes | % | Votes | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Appointment of a director (Mr. Marc Dunoyer) subject to condition precedent | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Carried | 25 945 461 | 98,65 | % | 354 396 | 1,35 | % | 16 497 | 26 299 857 | 21 466 266 | 29,917 | % | 0 | 0 | 29,917 | % | ||||||||||||||||||||||||||||||||||||||||
| 8 | Appointment of a director (Mr. Tyrell Rivers) subject to condition precedent | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Carried | 26 032 194 | 99,03 | % | 253 663 | 0,97 | % | 30 497 | 26 285 857 | 21 466 266 | 29,917 | % | 0 | 0 | 29,917 | % |